| Mode of action of an antiviral peptide from HIV-1: inhibition at a post-lipid mixing stage Y Kliger, SA Gallo, SG Peisajovich, I Munoz-Barroso, S Avkin, ... Journal of Biological Chemistry 276 (2), 1391-1397, 2001 | 204 | 2001 |
| Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion: structure-function study Y Kliger, A Aharoni, D Rapaport, P Jones, R Blumenthal, Y Shai Journal of Biological Chemistry 272 (21), 13496-13505, 1997 | 200 | 1997 |
| Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation Y Kliger, Y Shai Journal of molecular biology 295 (2), 163-168, 2000 | 121 | 2000 |
| Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy Y Kliger, EY Levanon BMC microbiology 3, 1-7, 2003 | 108 | 2003 |
| Discovery and validation of novel peptide agonists for G-protein-coupled receptors R Shemesh, A Toporik, Z Levine, I Hecht, G Rotman, A Wool, D Dahary, ... Journal of Biological Chemistry 283 (50), 34643-34649, 2008 | 92 | 2008 |
| A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers Y Kliger, Y Shai Biochemistry 36 (17), 5157-5169, 1997 | 90 | 1997 |
| Methods for SEM inspection of fluid containing samples V Behar, A Nechushtan, Y Kliger, O Gileadi, D Sprinzak, O Zik, Y Karni US Patent 7,230,242, 2007 | 88 | 2007 |
| Membrane-induced conformational change during the activation of HIV-1 gp41 Y Kliger, SG Peisajovich, R Blumenthal, Y Shai Journal of molecular biology 301 (4), 905-914, 2000 | 69 | 2000 |
| Peptides modulating conformational changes in secreted chaperones: from in silico design to preclinical proof of concept Y Kliger, O Levy, A Oren, H Ashkenazy, Z Tiran, A Novik, A Rosenberg, ... Proceedings of the National Academy of Sciences 106 (33), 13797-13801, 2009 | 48 | 2009 |
| Membrane-induced step in the activation of Sendai virus fusion protein I Ben-Efraim, Y Kliger, C Hermesh, Y Shai Journal of molecular biology 285 (2), 609-625, 1999 | 48 | 1999 |
| Reducing phylogenetic bias in correlated mutation analysis H Ashkenazy, Y Kliger Protein Engineering, Design & Selection 23 (5), 321-326, 2010 | 34 | 2010 |
| Optimal data collection for correlated mutation analysis H Ashkenazy, R Unger, Y Kliger Proteins: Structure, Function, and Bioinformatics 74 (3), 545-555, 2009 | 30 | 2009 |
| From genome to antivirals: SARS as a test tube Y Kliger, EY Levanon, D Gerber Drug discovery today 10 (5), 345-352, 2005 | 26 | 2005 |
| Computational approaches to therapeutic peptide discovery Y Kliger Peptide Science 94 (6), 701-710, 2010 | 22 | 2010 |
| Bioactive peptides and methods of using same R Shemesh, Z Levine, A Toporik, C Hermesh, Y Klinger, E Gofer, A Wool, ... US Patent 8,492,329, 2013 | 21 | 2013 |
| Activation of relaxin‐related receptors by short, linear peptides derived from a collagen‐containing precursor R Shemesh, C Hermesh, A Toporik, Z Levine, A Novik, A Wool, Y Kliger, ... Annals of the New York Academy of Sciences 1160 (1), 78-86, 2009 | 21 | 2009 |
| A novel angiopoietin‐derived peptide displays anti‐angiogenic activity and inhibits tumour‐induced and retinal neovascularization GM Palmer, Z Tiran, Z Zhou, ME Capozzi, W Park, C Coletta, A Pyriochou, ... British journal of pharmacology 165 (6), 1891-1903, 2012 | 19 | 2012 |
| Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases Z Levine, G Rotman, L Dassa, O Levy, GS Cojocaru, A Toporik, Y Kliger, ... US Patent App. 15/066,905, 2016 | 17 | 2016 |
| Large‐scale analysis of secondary structure changes in proteins suggests a role for disorder‐to‐order transitions in nucleotide binding proteins A Dan, Y Ofran, Y Kliger Proteins: Structure, Function, and Bioinformatics 78 (2), 236-248, 2010 | 17 | 2010 |
| Angiopoietin derived peptides Y Kliger, I Borukhov, O Levy, Z Tiran, A Wool, E Schreiber, A Amir, ... US Patent 8,529,943, 2013 | 16 | 2013 |
Itamar BorukhovPrincipal Scientist, Algorithmic Research, Research & Development, Compugen Ltd.Verified email at cgen.com